Clinical Trial Update: A Dose-escalation Clinical Study of Intraoperative Photodynamic Therapy of Glioblastoma [Phase 1, Phase 2]

View source ↗

Summary

Dose-escalation Phase 1/2 clinical trial evaluating intraoperative photodynamic therapy for glioblastoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Snippet

Sponsor: Hemerion Therapeutics | Conditions: Primary Glioblastoma | Phase 1, Phase 2 | Status: RECRUITING